Richard A. Graham, SVP, RESEARCH & DEVELOPMENT at Theravance Biopharma, Inc. (TBPH), sold 2,482 shares at $10.22 ($25K) on 2023-11-14, disclosed to the SEC on 2023-11-16.
Scheduled sale ($25k) by SVP, RESEARCH & DEVELOPMENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TBPH | SELL | 2023-08-15 | $23K | — | Filing → |
| TBPH | SELL | 2023-07-18 | $23K | — | Filing → |
| TBPH | SELL | 2023-06-16 | $25K | — | Filing → |